InspireMD Inc (NYSEAMERICAN:NSPR) Sees Significant Increase in Short Interest

InspireMD Inc (NYSEAMERICAN:NSPR) saw a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 177,306 shares, a growth of 60.7% from the February 15th total of 110,307 shares. Based on an average daily trading volume, of 585,137 shares, the days-to-cover ratio is presently 0.3 days. Currently, 2.5% of the shares of the stock are short sold.

NYSEAMERICAN:NSPR traded down $0.31 during mid-day trading on Monday, reaching $1.04. The stock had a trading volume of 2,247,900 shares, compared to its average volume of 672,366. InspireMD has a one year low of $0.70 and a one year high of $36.75.

How to Become a New Pot Stock Millionaire

InspireMD (NYSEAMERICAN:NSPR) last announced its quarterly earnings data on Wednesday, February 14th. The medical equipment provider reported ($7.38) earnings per share for the quarter. InspireMD had a negative net margin of 179.74% and a negative return on equity of 720.33%. The company had revenue of $0.83 million during the quarter.

ILLEGAL ACTIVITY NOTICE: This article was published by Enterprise Leader and is the property of of Enterprise Leader. If you are reading this article on another website, it was illegally stolen and republished in violation of international copyright and trademark laws. The legal version of this article can be read at https://theenterpriseleader.com/2018/04/02/inspiremd-inc-nyseamericannspr-sees-large-increase-in-short-interest.html.

About InspireMD

InspireMD, Inc is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures.

Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply